As predicted, disruption of the FGL2/PPBP paracrine loop through FGL2 knockout and anti-PPBP antibody binding significantly suppresses the tumorigenic effects of FGL2 and prolongs survival in tumour-bearing mice [75]. The gene discussed is FGL2; the disease is neoplasm.